- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
Panoptx launches new logo, new models, new technology
Panoptx has launched a new logo with a stylized number 7, tied to a new brand (7EYE), along with a renewed emphasis on the treatment of dysfunctional tear syndrome (DTS) and servicing independent dispensaries that care for patients with DTS symptoms.
Pleasanton, CA-Panoptx has launched a new logo with a stylized number 7, tied to a new brand (7EYE), along with a renewed emphasis on the treatment of dysfunctional tear syndrome (DTS) and servicing independent dispensaries that care for patients with DTS symptoms.
Explaining the rationale behind the new name, Bob Hall, Panoptx president and chief executive officer, said, "We wanted a name with instant recognition, a logo that would stand out, a domain name that people could spell, a name with youthful energy and attitude. We found that combination with the 7EYE logo and brand.
The first Panoptx frames bearing the 7EYE logo are being introduced as 7EYE by Panoptx Limited Edition III series to the motorcycle market, where Panoptx first became a hit among Harley-Davidson riders.
"The introduction of 7EYE is the beginning of a new platform for product development," Hall continued.
"We are creating a solid foundation for brand expansion and sales growth, and with new styles and new technology in the pipeline, 7EYE will fuel that growth."
